Effect of Midazolam as Premedication in Patients Undergoing Breast Conservation Study

Shaukat Khanum Memorial Cancer Hospital & Research Centre

Status: Completed

Conditions: Anxiety

Treatments: Drug: To measure anxiolysis, satisfaction level of patient after receiving Midazolam

Study type: Observational

Funder types: Other

Identifiers

NCT07184125

IRB-23-27

Details and patient eligibility

About

Patient are randomized into 2 groups under computer registered numbers. Patient anxiety score is calculated through APAIS SCORE. Then one group is given Midazolam, and the other group is given normal saline and then after one day patients satisfaction is calculated through Lppsq scale.

Full description

Patient are randomized into 2 groups under computer registered numbers. After taking approval from hospital ethical committee, 124 females fulfilling inclusion criteria are selected. All patients will receive written information about the study on the day before surgery and before signing informed consent. Patient anxiety score is calculated through APAIS SCORE. Then one group is given Midazolam, and the other group is given normal saline and then after one day patients satisfaction is calculated through Lppsq scale.

Enrollment: 124 patients

Sex: Female

Ages: Under 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. All patients undergoing breast conservation surgery
2. ASA I-II

Exclusion criteria

1. Patients already on anxiolytic medication
2. Pregnancy
3. Allergy to Midazolam,
4. Patient with diagnosed psychosis,
5. Chronic kidney disease.

Trial design

124 participants in 1 patient group

1 group will be given Midazolam

Description:

2nd group will be given normal saline

Treatment:

Drug: To measure anxiolysis, satisfaction level of patient after receiving Midazolam